The Asahi Intecc PTCA Chronic Total Occlusion Study

NACompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Coronary Artery DiseaseCoronary Artery Chronic Total Occlusion
Interventions
DEVICE

Crossing of Coronary Artery CTO

"Standard angiographic procedures will be followed for this study. The primary objective of this trial is to evaluate confirmation of placement of any guidewire beyond the chronic total occlusion (CTO) in the true vessel lumen in patients in which at least one Asahi series of guidewires and/or Corsair microcatheter were used.~Procedure success will be defined as angiographic visualization of any guidewire in a position either distal or proximal to the occlusion depending on the route of access and the absence of in-hospital MACE.~Other Name: ASAHI Corsair Microcatheter, ASAHI PTCA Guide Wires"

Trial Locations (12)

10032

Columbia University Medical Center/New York Presbyterian Hospital, New York

17403

York Hospital, York

30309

Piedmont Healthcare, Atlanta

48202

Henry Ford Hospital, Detroit

60181

Advocate Health and Hospitals Corp., Oakbrook Terrace

64111

Saint Luke's Hospital, Kansas City

75216

Dallas VA Medical Center, Dallas

80538

Medical Center of the Rockies, Loveland

85006

Banner - University Medical Center Phoenix, Phoenix

97477

PeaceHealth Sacred Heart Medical Center, Springfield

98195

University of Washington, Seattle

00029

Mount Sinai Hospital, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medpace, Inc.

INDUSTRY

lead

Asahi Intecc USA Inc

INDUSTRY

NCT02379923 - The Asahi Intecc PTCA Chronic Total Occlusion Study | Biotech Hunter | Biotech Hunter